Phio Pharmaceuticals Corp expected to post a loss of $4.59 a share - Earnings Preview

Phio Pharmaceuticals

06/08/2024 12:38

* Phio Pharmaceuticals Corp  PHIO.OQ   PHIO.O  is expected
to report resultson August 8 (estimated) for the period ending
June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Phio Pharmaceuticals
Corp is
for a loss of $4.59 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for Phio
Pharmaceuticals Corp is $36.00​, above​ its last closing price
of $2.77. ​​​

This summary was machine generated August 6 at 11:38 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)